» Articles » PMID: 33598796

Tissue Micro-RNAs Associated with Colorectal Cancer Prognosis: a Systematic Review

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2021 Feb 18
PMID 33598796
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is a multifactorial disease commonly diagnosed worldwide, with high mortality rates. Several studies demonstrate important associations between differential expression of micro-RNAs (miRs) and the prognosis of CRC. The present study aimed to identify differentially expressed tissue miRs associated with prognostic factors in CRC patients, through a systematic review of the Literature. Using the PubMed database, Cochrane Library and Web of Science, studies published in English evaluating miRs differentially expressed in tumor tissue and significantly associated with the prognostic aspects of CRC were selected. All the included studies used RT-PCR (Taqman or SYBR Green) for miR expression analysis and the period of publication was from 2009 to 2018. A total of 115 articles accomplished the inclusion criteria and were included in the review. The studies investigated the expression of 100 different miRs associated with prognostic aspects in colorectal cancer patients. The most frequent oncogenic miRs investigated were miR-21, miR-181a, miR-182, miR-183, miR-210 and miR-224 and the hyperexpression of these miRs was associated with distant metastasis, lymph node metastasis and worse survival in patients with CRC. The most frequent tumor suppressor miRs were miR-126, miR-199b and miR-22 and the hypoexpression of these miRs was associated with distant metastasis, worse prognosis and a higher risk of disease relapse (worse disease-free survival). Specific tissue miRs are shown to be promising prognostic biomarkers in patients with CRC, given their strong association with the prognostic aspects of these tumors, however, new studies are necessary to establish the sensibility and specificity of the individual miRs in order to use them in clinical practice.

Citing Articles

MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients.

Fabijanec M, Hulina-Tomaskovic A, Stefanovic M, Verbanac D, Celap I, Somborac-Bacura A Int J Mol Sci. 2024; 25(15).

PMID: 39125725 PMC: 11311302. DOI: 10.3390/ijms25158156.


Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance.

Belnap C, Divis T, Kingsley K, Howard K Int J Mol Sci. 2024; 25(4).

PMID: 38396844 PMC: 10889714. DOI: 10.3390/ijms25042167.


Sodium Butyrate Inhibits the Malignant Proliferation of Colon Cancer Cells via the miR-183/DNAJB4 Axis.

Pan D, Hao J, Wu T, Shen T, Yu K, Li Q Biochem Genet. 2024; 62(5):4174-4190.

PMID: 38244156 DOI: 10.1007/s10528-023-10599-z.


Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.

Kasprzak A Cancers (Basel). 2023; 15(18).

PMID: 37760539 PMC: 10526446. DOI: 10.3390/cancers15184570.


Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis.

Junior A, Ferreira L, Barbosa L, de Melo E Silva D, Saddi V, Silva A Noncoding RNA. 2023; 9(1).

PMID: 36827546 PMC: 9967089. DOI: 10.3390/ncrna9010013.

References
1.
Wilhelmsen M, Kring T, Jorgensen L, Madsen M, Jess P, Bulut O . Determinants of recurrence after intended curative resection for colorectal cancer. Scand J Gastroenterol. 2014; 49(12):1399-408. DOI: 10.3109/00365521.2014.926981. View

2.
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T . Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62(4):220-41. DOI: 10.3322/caac.21149. View

3.
Pardini B, Rosa F, Naccarati A, Vymetalkova V, Ye Y, Wu X . Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Carcinogenesis. 2014; 36(1):82-6. DOI: 10.1093/carcin/bgu224. View

4.
Hansen T, Christensen R, Andersen R, Sorensen F, Johnsson A, Jakobsen A . MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Br J Cancer. 2013; 109(5):1243-51. PMC: 3778299. DOI: 10.1038/bjc.2013.448. View

5.
Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland C . Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg. 2013; 259(4):735-43. PMC: 4032090. DOI: 10.1097/SLA.0b013e3182a6909d. View